
Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGene in China
– Collaboration with BeiGene is part of Immune-Onc’s global clinical development strategy targeting the LILRB family of myeloid checkpoints – PALO ALTO, Calif.–(BUSINESS WIRE)–#ILT3–Immune-Onc Therapeutics, […]













